Supernus secures seven years of ONAPGO exclusivity
Supernus (NASDAQ:SUPN) announced FDA recognition of seven years of orphan-drug exclusivity for ONAPGO, its treatment for motor fluctuations in advanced Parkinson's disease.
Supernus (NASDAQ:SUPN) announced FDA recognition of seven years of orphan-drug exclusivity for ONAPGO, its treatment for motor fluctuations in advanced Parkinson's disease.
Mid Penn Bancorp (NASDAQ:MPB) reported third-quarter 2026 net income available to common shareholders of $21.6 million, up 18.2% year over year.
Pharming Group (NASDAQ:PHAR) expects third-quarter 2026 revenue of approximately US$117.6 million, up 21% year over year, according to preliminary unaudited results.
argenx (NASDAQ:ARGX) reported third-quarter 2026 global product net sales of $1.7 billion, up 54%, supported by continued VYVGART sales growth.
Chinese prosecutors are seeking to confiscate 61,896 Bitcoin linked to an alleged investment fraud that raised more than 40.37 billion yuan, according to a report by The Paper.
Nokia (NYSE:NOK) reported third-quarter 2026 net sales of €5.154 billion, up 10%, while reported operating profit declined 22% to €196 million.
Oculis (NASDAQ:OCS) reported new Phase 2 ACUITY findings showing reduced nerve injury biomarker increases with Privosegtor versus placebo at Day 5.
Aero launched on 21 October 2026, merging Aerodrome and Velodrome into one decentralised trading platform across seven blockchain networks.
Grayscale has expanded in-kind subscriptions across 10 digital asset investment products, allowing eligible investors to exchange crypto holdings for product shares.
A federal court judge ordered Apple (NASDAQ:AAPL) to allow alternative app stores and permit the video game Fortnite to return to its platform.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy